Bought
Maintained
Sold
Other funds holding MDT
Amundi's MDT Position: Q2 2026 in Review
Amundi reduced its Medtronic (MDT) stake by 4.1% in Q2 2026, selling an estimated $19.9M and leaving 5,824,040 shares worth $456M. The position accounts for 0.11% of the portfolio, ranked #167.
Amundi first reported a position in MDT in Q2 2021 and has held it in 21 quarters since. The position peaked at $921M in Q2 2021. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Amundi held 5,824,040 shares of Medtronic worth $456M as of Q2 2026.
- Amundi sold 246,196 Medtronic shares in Q2 2026, an estimated $19.9M.
- Medtronic made up 0.11% of Amundi's portfolio in Q2 2026, its #167 holding.
- Amundi first reported a position in Medtronic in Q2 2021 and has held it in 21 quarters since.
- Amundi's Medtronic position peaked at $921M in Q2 2021.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.